Two-Year Follow Up of a First-in-Man Registry with a Bioabsorbable Polymer Based Sirolimus-Eluting Stent (Medistra Excel Drug-Eluting Stent Trial - MEDISTRA Study)

- Presenter : Teguh Santoso